Spire Wealth Management increased its stake in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 43.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 49,036 shares of the medical research company’s stock after buying an additional 14,966 shares during the period. Spire Wealth Management’s holdings in Agilent Technologies were worth $6,435,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds also recently added to or reduced their stakes in the stock. OFI Invest Asset Management purchased a new position in shares of Agilent Technologies during the 3rd quarter worth approximately $25,000. MV Capital Management Inc. raised its holdings in shares of Agilent Technologies by 120.7% in the fourth quarter. MV Capital Management Inc. now owns 192 shares of the medical research company’s stock worth $27,000 after acquiring an additional 105 shares during the last quarter. Baystate Wealth Management LLC raised its holdings in shares of Agilent Technologies by 107.3% in the fourth quarter. Baystate Wealth Management LLC now owns 257 shares of the medical research company’s stock worth $36,000 after acquiring an additional 133 shares during the last quarter. Column Capital Advisors LLC raised its holdings in shares of Agilent Technologies by 1,111.1% in the third quarter. Column Capital Advisors LLC now owns 327 shares of the medical research company’s stock worth $37,000 after acquiring an additional 300 shares during the last quarter. Finally, Rosenberg Matthew Hamilton raised its holdings in shares of Agilent Technologies by 51.1% in the fourth quarter. Rosenberg Matthew Hamilton now owns 284 shares of the medical research company’s stock worth $39,000 after acquiring an additional 96 shares during the last quarter.
Agilent Technologies Stock Up 0.8 %
NYSE A traded up $1.16 on Monday, hitting $140.61. 1,639,410 shares of the stock traded hands, compared to its average volume of 1,530,458. The stock has a 50-day moving average of $142.07 and a 200 day moving average of $131.79. Agilent Technologies, Inc. has a twelve month low of $96.80 and a twelve month high of $151.58. The company has a market capitalization of $41.21 billion, a P/E ratio of 33.20, a price-to-earnings-growth ratio of 4.22 and a beta of 1.13. The company has a current ratio of 2.68, a quick ratio of 2.04 and a debt-to-equity ratio of 0.41.
Agilent Technologies Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Wednesday, April 24th. Stockholders of record on Tuesday, April 2nd were given a dividend of $0.236 per share. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date of this dividend was Monday, April 1st. Agilent Technologies’s payout ratio is 22.38%.
Wall Street Analyst Weigh In
Several equities analysts recently commented on A shares. Evercore ISI upped their target price on Agilent Technologies from $132.00 to $145.00 and gave the company an “in-line” rating in a research note on Thursday, April 4th. Stifel Nicolaus raised Agilent Technologies from a “hold” rating to a “buy” rating and boosted their price target for the company from $145.00 to $163.00 in a research report on Friday, April 5th. Oppenheimer boosted their price target on Agilent Technologies from $67.00 to $90.00 and gave the company an “outperform” rating in a research report on Tuesday, March 26th. Barclays boosted their price target on Agilent Technologies from $125.00 to $135.00 and gave the company an “underweight” rating in a research report on Wednesday, April 10th. Finally, UBS Group boosted their price target on Agilent Technologies from $130.00 to $155.00 and gave the company a “neutral” rating in a research report on Wednesday, February 28th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $141.29.
Read Our Latest Report on Agilent Technologies
Insider Transactions at Agilent Technologies
In other news, Director Heidi Fields sold 1,658 shares of the stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $144.34, for a total transaction of $239,315.72. Following the sale, the director now directly owns 54,976 shares in the company, valued at approximately $7,935,235.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CEO Michael R. Mcmullen sold 52,297 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $150.00, for a total value of $7,844,550.00. Following the sale, the chief executive officer now directly owns 253,909 shares in the company, valued at approximately $38,086,350. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Heidi Fields sold 1,658 shares of the firm’s stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $144.34, for a total value of $239,315.72. Following the completion of the sale, the director now owns 54,976 shares in the company, valued at $7,935,235.84. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 61,610 shares of company stock worth $9,220,333.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Further Reading
- Five stocks we like better than Agilent Technologies
- How to Buy Cheap Stocks Step by Step
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- What is the Euro STOXX 50 Index?
- 3 Value Stocks You Can Buy Before They Become Big
- With Risk Tolerance, One Size Does Not Fit All
- Chinese Stocks Stage Impressive Rebound
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.